CDK7 and cancer: Since CDK7, CDK8/19, CDK12/13, or CDK9 are associated with basal RNA transcription, it seemed a reasonable strategy to selectively target these CDKs, as cancer cells may be particularly susceptible to selective suppression (Figure 8).